Skip to main content

Advertisement

SpringerLink
Log in

N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Polymorphisms that alter the function of genes involved in the activation or detoxification of carcinogenic compounds can influence an individuals risk of developing cancer. Polymorphic changes modulating the acetylation capacity of the N-acetyltransferase (NAT) genes have been implicated in the risk of developing cancer. In this study the role of genetically determined individual NAT1 and NAT2 genotypes, haplotypes and haplotype combinations in the predisposition to head and neck cancer was investigated. Polymorphic regions of the NAT1 and NAT2 genes were analyzed in patients with head and neck cancer and healthy individuals by polymerase chain reaction-restriction fragment length polymorphism. Distribution of the genotypes, allele frequencies, diplotypes and haplotypes and correlation with clinical characteristics were evaluated. No association was observed between the NAT1*3, NAT1*10, NAT1*11, NAT2*5 and NAT2*6 genotypes and risk of head and neck cancer. The NAT2*7 slow genotype was associated with reduced risk of disease. A significant association was observed between the fast acetylator NAT2*4/NAT1*10 diplotype and risk of head and neck cancer. Combined haplotypes harboring the T1088A and C1095A variants characterizing the NAT1*10 allele were associated with increased risk. Our results suggest that NAT1 and NAT2 gene combinations may influence the risk of developing head and neck cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sturgis EM, Wei Q (2002) Genetic susceptibility—molecular epidemiology of head and neck cancer. Curr Opin Oncol 14:310–317

    Article  PubMed  Google Scholar 

  2. Mohrenweiser HW (2004) Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm. Toxicol Pathol 32(Supp 1):136–145

    Article  CAS  PubMed  Google Scholar 

  3. Millerill MC, Mohrenweiser HW, Bell DA (2001) Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120:269–280

    Article  Google Scholar 

  4. Huang WY, Olshan AF, Scheartz SM, Berndt SI, Chen C, Llaca V, Chanock SJ, Fraumeni JF, Hayes RB (2005) Selected genetic polymorphsms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 14:1747–1753

    Article  CAS  PubMed  Google Scholar 

  5. Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Their R, Vetter H, Ko YD, Brüning T, Bolt HM, Ickstadt K (2008) Head and neck squamous cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 71:887–897

    Article  CAS  PubMed  Google Scholar 

  6. Tripathy CB, Roy N (2006) Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28:217–224

    Article  PubMed  Google Scholar 

  7. Capolungo E, Almadori G, Concolino P, Bussu F, Santonocito C, Venditelli F, Galli J, Zuppi C, Ameglio F, Paludetti G, Giardina B (2007) GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio region. Clin Chem Acta 376:174–178

    Article  Google Scholar 

  8. Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Brode P, Vetter H, Blt HM, Pesch B, Brüning T (2004) Association of cytochrome P4502E1 polymorphisms and head and neck cancer. Toxicol Lett 151:273–282

    Article  CAS  PubMed  Google Scholar 

  9. Kowalski M, Przybylowska K, Rusin P, Olzewski S, Morawiec-Sztandera A, Bielecka-Kowalska A, Pietruszewska W, Mlynarski W, Szemaraj J, Majsterek I (2009) Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 13:28–37

    Google Scholar 

  10. Boccia S, Cadoni G, Sayed-Tabatabaei F, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, van Duijn CM, Paludetti G, Ricciardi G (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93–100

    Article  CAS  PubMed  Google Scholar 

  11. Geissler SA, Olshan AF, Cai J, Weissler M, Smith J, Bell D (2005) Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck 27:232–242

    Article  Google Scholar 

  12. Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, Matsuo K, van Duijn CM, Hung RJ (2009) Meta-analyses of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett 273:55–61

    Article  CAS  PubMed  Google Scholar 

  13. Chen K, Zhao H, Hu Z, Wang LE, Zhang W, Sturgis EM, Wei Q (2008) CASP8 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 14:6343–6349

    Article  CAS  PubMed  Google Scholar 

  14. Agundez JAG (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9:520–531

    Article  CAS  PubMed  Google Scholar 

  15. Fronhoffs S, Brüning T, Ortiz-Pallardo E, Bröde P, Koch B, Harth V, Sachinidis A, Bolt HM, Herberhold C, Vetter H, Ko Y (2001) Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3,*4,*10,*11,*14 and *17 polymorphism in squamous cell cancer of head and neck. Carcinogenesis 22:1405–1412

    Article  CAS  PubMed  Google Scholar 

  16. Boukouvala S, Sim E (2005) Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts. Basic Clin Pharmacol Toxicol 96:343–351

    Article  CAS  PubMed  Google Scholar 

  17. Jaskula-Sztul R, Sokolowski W, Gajecka M, Szyfter K (2001) Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk. J Appl Genet 42:223–231

    Article  CAS  PubMed  Google Scholar 

  18. Hein DW (2002) Molecular genetics and function of the NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506–507:65–77

    PubMed  Google Scholar 

  19. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JR, Hassan MM (2006) Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27:103–111

    Article  PubMed  Google Scholar 

  20. Varzim G, Monteiro E, Silva R, Pinheiro C, Lopes C (2002) Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility. ORL J Otorhinolaryngol Relat Spec 64:206–212

    CAS  PubMed  Google Scholar 

  21. Bouchardy C, Mitrunen K, Wikman H, Husgafuel-Pursiainen K, Dayer P, Benhamou S, Hirvonen A (1998) N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics 8:291–298

    Article  CAS  PubMed  Google Scholar 

  22. Katoh T, Boissy R, Nagata N, Kitagawa K, Kuroda Y, Itoh H, Kawamoto T, Bell DA (2000) Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 85:46–49

    Article  CAS  PubMed  Google Scholar 

  23. Garcia-Closas M, Malats N, Siverman D, Dosemeci M, Kogewinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tota M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 genotype and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649–659

    Article  CAS  PubMed  Google Scholar 

  24. Lee CN, Yu MC, Bai KJ, Chang JH, Fang CL, Hsu HL, Huang BS, Lu PC, Liu HE (2009) NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wild type epidermal growth factor receptors in Taiwan. Lung Cancer 64:9–12

    Article  PubMed  Google Scholar 

  25. Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J (2008) Cigarette smoking, N-acetyltransferase 2 genotypes and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 17:15–26

    Article  CAS  PubMed  Google Scholar 

  26. Wachholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92:1151–1158

    Article  Google Scholar 

  27. Jiao L, Doll MA, Hein DW, Bondy ML, Hassan MM, Hixson JE, Abbruzzese JL, Li D (2007) Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemol Biomarkers Prev 16:2379–2386

    Article  CAS  Google Scholar 

  28. Ishibe N, Sinha R, Hein DW, Kulldorff M, Strickland P, Fretland AJ, Chow WH, Kadlubar FF, Lang NP, Rothman H (2002) Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics 12:145–150

    Article  CAS  PubMed  Google Scholar 

  29. Katoh T, Inatomi H, Yang M, Kawamato T, Matsumota T, Bell DA (1999) Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese. Pharmacogenetics 9:401–404

    Article  CAS  PubMed  Google Scholar 

  30. Hein DW, Leff MA, Ishibe N, Sinha R, Frasier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE (2002) Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 genotypes in a pilot case control study. Environ Mol Mut 40:161–167

    Article  CAS  Google Scholar 

  31. Krajinovic M, Ghadirian P, Richer C, Sinett H, Gandini S, Perret C, Lacroix A, Labuda D, Sinnett D (2001) Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 92:220–225

    Article  CAS  PubMed  Google Scholar 

  32. Wikman H, Thiel S, Jager B, Schmezer P, Spiegelhalder B, Edler L, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H, Risch A (2001) Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11:157–168

    Article  CAS  PubMed  Google Scholar 

  33. Boissy RJ, Watson MA, Umbach DM, Deakin M, Elder J, Strange RC, Bell DA (2000) A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int J Cancer 87:507–511

    Article  CAS  PubMed  Google Scholar 

  34. Zhang XF, Bian JC, Zhang XY, Zhang ZM, Jiang F, Wang QM, Wang QJ, Cao YY, Tang BM (2005) Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? World J Gastroenterol 11:1457–1462

    CAS  PubMed  Google Scholar 

  35. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A (2004) Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89:628–629

    CAS  PubMed  Google Scholar 

  36. Lee KM, Park SK, Kim SU, Doll MA, Yoo KY, Ahn SH, Noh DY, Hirvonen A, Hein DW, Kang D (2003) N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett 196:179–186

    Article  CAS  PubMed  Google Scholar 

  37. Chen J, Stampfer MJ, Hough HL, Garcia-Closas M, Willett WC, Hennekens CH, Kelsey KT, Hunter DJ (1998) A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58:3307–3311

    CAS  PubMed  Google Scholar 

  38. Cascorbi I, Roots I, Brockmoller J (2001) Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res 61:5051–5056

    CAS  PubMed  Google Scholar 

  39. Henning S, Cascorbi I, Munchow B, Kahnke V, Roots I (1999) Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 9:103–111

    Article  CAS  PubMed  Google Scholar 

  40. Frazier ML, O’Donnell FT, Kong S, Gu X, Campos I, Luthra R, Lynch PM, Amos CI (2001) Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res 61:1269–1271

    CAS  PubMed  Google Scholar 

  41. Unal M, Tamer L, Akbas Y, Pata YS, Vayisoglu Y, Degirmenci U, Camdeviren H (2005) Genetic polymorphism of N-acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma. Head Neck 27:1056–1060

    Article  PubMed  Google Scholar 

  42. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I (1996) Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 56:3961–3966

    CAS  PubMed  Google Scholar 

  43. Gajecka M, Rydzanicz M, Juskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112–123

    CAS  PubMed  Google Scholar 

  44. Szyfter K, Szmeja Z, Szyfter W, Hemminki K, Banaszewski J, Jaskula-Sztul R, Louhelainen J (1999) Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutat Res 445:259–274

    CAS  PubMed  Google Scholar 

  45. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE (2004) N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Int J Toxicol 23:25–31

    Article  CAS  PubMed  Google Scholar 

  46. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Roots I (1997) Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population. Pharmacogenetics 7:327–331

    Article  CAS  PubMed  Google Scholar 

  47. Borlak J, Reamon-Buettner SM (2006) N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med Genet 7:58

    Article  PubMed  Google Scholar 

  48. Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfield J, Hein DW, Hayes RB (2006) Cigarette smoking: N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 7:819–829

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Istanbul University Research Fund (Project Number: 368/03062005). We thank to Prof. Dr. Thomas Winkler for providing the statistics programme. The authors thank to Burak Erdamar, MD, for his assistance and coordinative support during the initial phase of the study.

Author information

Authors and Affiliations

  1. Department of Basic Oncology, I.U. Oncology Institute, 34093, Capa, Istanbul, Turkey

    Semra Demokan & Nejat Dalay

  2. Department of Otolaryngology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Yusufhan Suoglu, Mustafa Gözeler & Deniz Demir

Authors
  1. Semra Demokan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusufhan Suoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa Gözeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deniz Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nejat Dalay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nejat Dalay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demokan, S., Suoglu, Y., Gözeler, M. et al. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. Mol Biol Rep 37, 3217–3226 (2010). https://doi.org/10.1007/s11033-009-9905-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9905-8

Keywords

Search

Navigation